Solutions For Clinical Trials: Trusted ECG Data For Faster, More Flexible Trials

AliveCor’s clinical trial ECG solution redefines cardiac safety monitoring by addressing the inefficiencies of traditional workflows. With FDA-cleared 6-lead and 12-lead handheld devices, the platform offers remote and onsite flexibility, enabling fast, accurate, and auditable ECG data capture tailored to diverse trial designs. Proprietary AI delivers instant rhythm detection and QT interval analysis, while expert CoreLab overread ensures regulatory-grade accuracy. Structured data outputs are designed for seamless integration into submission workflows, reducing complexity for trial sponsors.

AliveCor’s approach enhances patient experience through self-administered capabilities, which reduce clinic visits and support higher adherence and lower dropout rates. Clinical teams benefit from faster decision-making, fewer site resource demands, and streamlined operations—ultimately reducing trial timelines and costs. The K1000 device provides 6-lead ECGs with instant detection of seven common arrhythmias and support for 20+ more through overread. The Kardia 12L captures full 12-lead ECGs with detection of 35 rhythms and morphologies, making it ideal for cardiology-led trials.